RV572: Standardized death rate by cause of death and sex

All datasets
Popular datasets

Reset

POPULATION
- Population indicators and composition
  - Main demographic indicators
  - Population figure and composition
- Vital events

EM001: Enterprises' income statement by economic activity (EMTAK 2008) and number of persons employed
IA001: Consumer price index, change over previous year
PA001: Average gross wages (salaries), labour cost, hours actually worked and number of employees by economic activity section (quarterly)
PA5211: Average monthly gross and net wages (salaries) by economic activity (EMTAK 2008)
RAA0012: Gross domestic product and gross national income (ESA 2010) (quarters)
RV021: Population by sex and age group, 1 January
RV0221U: Population by sex, age group and county, 1 January. estonians. administrative division as at 01.01.2018
RVR01: Migration by administrative unit/type of settlement, sex and type of migration
TU131: Accommodated tourists and nights spent by county and country of residence (months)
VK10_3: Exports and imports of goods by commodity (CN) and country 2017-2018
Pre-defined tables

>> Data by domain

RV572: Standardized death rate by cause of death and sex

Reference period		2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019


Cause of death by ICD-10	Sex
All causes	Males and females	1 077.19	1 087.28	1 065.70	1 046.02	1 010.74	977.89	963.44	948.70	885.31	831.85	793.00	754.53	745.92	712.29	1 225.19	1 226.26	1 211.59	1 192.04	1 188.68	1 138.68
	Males	1 529.30	1 568.67	1 531.47	1 512.01	1 474.84	1 432.12	1 422.82	1 411.81	1 304.00	1 225.22	1 167.58	1 105.81	1 099.95	1 023.08	1 740.88	1 455.75	1 449.12	1 419.39	1 402.64	1 345.33
	Females	773.98	762.87	744.12	737.72	698.09	680.19	664.23	641.30	610.13	575.25	553.91	523.84	512.03	508.10	924.21	718.73	702.70	694.63	684.20	661.87
Infectious and parasitic diseases (A00-B99)	Males and females	10.13	9.51	8.24	10.28	10.35	7.14	10.03	9.30	8.13	9.54	7.70	8.60	8.45	7.15	9.42	8.63	9.56	10.95	11.18	11.60
	Males	16.02	15.54	13.96	16.96	17.04	11.57	16.05	14.40	13.19	14.36	13.01	14.00	13.53	11.06	11.36	11.93	13.78	11.06	13.47	12.32
	Females	4.93	4.70	3.46	4.66	4.96	3.65	5.02	4.99	3.76	5.34	3.36	3.94	4.26	4.00	7.45	4.84	5.53	8.33	6.69	7.01
..tuberculosis (A15-A19, B90)	Males and females	7.23	6.27	5.96	6.36	6.71	3.30	4.47	4.05	3.49	2.96	2.53	2.71	2.24	1.45	1.92	1.62	2.14	1.81	0.81	1.20
	Males	12.50	11.36	11.52	11.51	12.90	6.42	7.63	7.38	5.87	4.96	5.31	5.81	4.42	2.62	2.96	2.96	4.04	2.88	1.80	1.53
	Females	2.73	2.46	1.43	2.18	1.96	1.20	1.95	1.36	1.33	1.73	0.51	0.54	0.43	0.55	1.15	0.59	0.54	0.77	0.00	0.46
..meningococcal infection (A39)	Males and females	0.12	0.19	0.00	0.04	0.08	0.00	0.00	0.12	0.19	0.00	0.00	0.00	0.00	0.10	0.00	0.00	0.00	0.07	0.00	0.00
	Males	0.28	0.24	0.00	0.15	0.00	0.00	0.00	0.00	0.22	0.00	0.00	0.00	0.00	0.20	0.00	0.00	0.00	0.00	0.00	0.00
	Females	0.00	0.14	0.00	0.00	0.14	0.00	0.00	0.24	0.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.15	0.00	0.00
..sepsis (A40-A41)	Males and females	1.20	0.97	1.11	1.72	0.76	0.55	0.59	0.15	0.27	0.64	0.35	0.18	0.69	0.32	1.54	1.67	1.60	2.82	2.39	4.46
	Males	1.34	1.39	1.06	1.78	0.64	0.75	1.01	0.14	0.39	0.96	0.59	0.15	1.32	0.60	1.27	1.61	2.13	1.96	2.75	3.60
	Females	1.03	0.51	1.11	1.68	0.76	0.35	0.29	0.15	0.26	0.32	0.16	0.18	0.30	0.18	1.78	1.29	0.70	2.37	1.39	3.00
..viral hepatitis(B15-B19)	Males and females	..	..	..	0.38	0.25	0.14	0.56	0.42	0.45	0.92	0.22	0.48	0.57	0.72	0.84	0.46	0.64	0.64	0.86	0.30
	Males	..	..	..	0.69	0.44	0.15	0.71	0.56	0.91	1.47	0.48	0.59	0.48	1.22	0.48	0.70	1.23	0.59	0.78	0.30
	Females	..	..	..	0.11	0.06	0.14	0.46	0.34	0.00	0.38	0.00	0.33	0.58	0.40	1.12	0.29	0.23	0.56	0.83	0.27
..HIV-disease (B20-B24)	Males and females	0.20	0.21	0.21	0.50	1.58	2.42	3.62	3.09	3.13	3.79	3.13	4.49	3.99	3.57	3.29	3.24	3.23	2.74	3.41	2.86
	Males	0.43	0.43	0.41	1.02	2.03	3.62	5.34	4.28	4.47	6.07	4.74	7.20	5.76	5.29	4.86	4.81	3.69	3.41	5.02	4.42
	Females	0.00	0.00	0.00	0.00	1.12	1.16	1.94	1.93	1.77	1.51	1.52	1.80	2.26	1.85	1.64	1.58	2.77	2.03	1.82	1.31
Neoplasms (C00-D48)	Males and females	199.86	195.32	198.63	192.46	197.61	196.39	198.80	192.80	189.79	187.56	185.38	186.58	185.23	181.07	302.08	303.02	293.58	291.70	297.92	285.87
	Males	294.88	290.81	299.01	292.29	302.01	305.71	300.68	296.78	288.07	285.05	288.32	280.24	281.39	273.60	474.76	433.06	413.80	417.41	417.44	402.51
	Females	149.47	143.25	143.27	137.61	142.54	137.31	144.66	135.68	136.38	136.96	130.38	136.71	134.27	132.03	218.45	197.79	195.28	197.12	195.04	191.16
..malignant neoplasms (C00-C97)	Males and females	198.52	193.62	197.00	191.13	195.01	193.97	196.06	190.19	187.67	184.46	182.82	183.98	182.47	178.07	296.13	296.07	285.52	284.80	289.01	277.18
	Males	292.99	289.11	296.74	290.66	299.31	302.40	296.94	293.78	284.68	280.51	284.72	276.56	277.28	270.55	465.28	426.66	405.50	410.27	408.34	393.81
	Females	148.47	141.51	142.04	136.30	139.93	135.43	142.25	133.09	134.81	134.66	128.42	134.54	132.46	128.95	214.37	192.63	190.06	191.68	188.80	184.16
....malignant neoplasm of lip, oral cavity and pharynx (C00-C14)	Males and females	6.22	7.70	6.58	4.68	5.16	7.08	4.70	5.10	5.68	5.05	7.84	4.99	6.38	5.66	7.12	7.18	7.09	7.14	8.16	7.56
	Males	13.21	15.32	12.36	9.94	9.74	14.56	9.70	11.44	10.12	9.56	15.90	9.60	13.72	11.02	15.02	14.93	15.16	12.62	16.41	14.43
	Females	1.72	2.25	2.51	1.14	2.04	2.02	1.27	0.73	2.61	1.96	2.06	1.86	1.32	2.10	1.85	1.94	1.78	2.53	2.16	2.64
....malignant neoplasm of oesophagus (C15)	Males and females	2.67	3.32	2.74	2.84	3.64	3.47	3.48	2.66	3.41	3.70	3.61	3.36	4.33	2.36	5.74	5.29	6.40	5.35	5.10	6.79
	Males	6.34	7.49	5.47	6.00	7.64	7.91	7.54	5.57	7.47	8.05	7.34	7.18	8.33	4.60	11.59	11.39	13.53	10.81	11.33	13.47
	Females	0.36	0.65	0.84	0.75	1.04	0.59	0.48	0.77	0.58	0.87	1.25	0.62	1.71	1.06	2.14	1.15	1.73	1.81	1.19	2.11
....malignant neoplasm of stomach (C16)	Males and females	21.08	19.74	19.99	19.29	19.27	17.62	20.41	17.97	15.37	16.27	14.51	14.88	14.44	14.26	23.96	21.42	20.88	20.35	21.81	19.75
	Males	33.02	30.27	29.73	29.36	27.87	24.98	32.23	28.37	22.57	22.25	23.55	24.09	23.15	23.25	38.50	29.79	30.11	28.50	26.85	28.68
	Females	13.98	13.48	13.93	14.00	14.17	13.00	13.84	11.98	11.04	12.27	9.63	8.88	9.32	8.96	16.59	13.79	12.98	14.17	16.55	13.05
....malignant neoplasm of colon and rectosigmoid junction (C18, C19)	Males and females	..	..	..	10.98	14.04	13.88	14.27	13.47	13.75	14.17	12.64	13.86	12.67	13.52	26.12	26.18	27.82	27.64	26.53	25.70
	Males	..	..	..	14.45	17.40	18.54	16.89	17.10	19.24	20.85	18.61	17.68	16.76	18.61	40.44	32.30	31.70	36.36	30.99	36.57
	Females	..	..	..	9.04	12.05	11.33	13.13	11.68	10.86	10.62	9.84	12.01	10.97	11.32	20.27	19.99	20.19	18.58	19.58	16.50
....malignant neoplasm of colon (C18)	Males and females	..	11.88	..	11.38	13.48	12.99	12.79	12.45	12.64	12.70	11.22	12.42	10.93	11.69	22.81	22.87	24.99	24.49	23.53	21.73
	Males	..	15.73	..	15.24	16.77	17.79	15.13	15.67	16.90	19.01	16.59	15.75	14.32	16.51	34.53	28.10	28.35	32.02	26.95	30.48
	Females	..	9.86	..	9.23	11.54	10.31	11.83	10.84	10.32	9.38	8.58	10.86	9.34	9.58	18.17	17.64	18.12	16.33	17.69	14.00
....malignant neoplasm of colon and rectosigmoid junction (C19)	Males and females	..	..	15.07	0.39	0.57	0.90	1.47	1.04	1.12	1.47	1.42	1.42	1.74	1.83	3.31	3.31	2.82	3.15	3.00	3.97
	Males	..	..	20.51	0.78	0.63	0.74	1.75	1.42	2.35	1.83	2.03	1.92	2.46	2.09	5.91	4.20	3.35	4.34	4.04	6.10
	Females	..	..	12.88	0.20	0.50	1.02	1.29	0.84	0.54	1.24	1.26	1.14	1.63	1.73	2.10	2.35	2.06	2.25	1.89	2.50
....malignant neoplasm of rectum and anus (C20, C21)	Males and females	..	8.46	7.05	7.58	7.47	8.08	7.71	6.88	5.71	6.53	6.88	6.23	6.20	6.73	9.52	10.13	9.86	9.59	10.16	10.28
	Males	..	12.74	9.26	10.88	9.85	12.80	14.36	11.95	8.35	9.82	10.54	11.45	10.87	10.01	13.17	14.89	12.89	16.48	14.26	16.15
	Females	..	6.30	6.06	5.84	6.67	5.63	4.32	4.38	4.12	4.91	4.69	3.43	3.86	4.90	7.72	6.36	6.64	5.11	6.86	5.52
....malignant neoplasm of liver and intrahepatic bile ducts (C22)	Males and females	5.57	4.48	5.43	4.34	4.54	4.64	4.39	3.99	4.54	5.22	5.25	4.27	4.82	4.74	6.49	7.74	9.75	9.02	9.24	7.65
	Males	8.44	6.78	8.96	5.73	8.12	7.70	5.80	6.24	7.31	7.59	8.89	6.53	6.84	8.09	8.93	13.79	13.95	14.02	14.09	12.90
	Females	3.83	3.38	2.94	3.42	2.62	3.01	3.41	2.77	2.60	3.75	3.34	2.82	3.69	2.74	4.87	4.23	6.09	5.64	5.44	3.92
....malignant neoplasm of pancreas (C25)	Males and females	10.07	10.64	10.32	11.63	10.49	9.25	12.41	11.14	12.16	12.84	11.08	12.66	10.43	12.53	19.58	18.47	16.74	16.99	22.01	19.19
	Males	14.27	15.21	13.56	16.23	15.21	13.94	17.32	15.46	15.52	15.83	15.96	17.17	14.92	18.05	23.72	22.80	18.50	17.83	27.19	22.36
	Females	7.54	7.24	7.83	8.91	7.38	6.27	9.39	8.12	10.16	10.37	8.11	9.69	7.78	8.81	16.85	13.40	14.05	14.23	16.94	15.53
....malignant neoplasms of respiratory organs (C30-39)	Males and females	..	..	..	43.88	41.31	39.97	42.65	41.76	40.69	35.47	36.39	36.31	37.98	36.49	58.60	56.04	55.59	51.44	53.59	51.23
	Males	..	..	..	97.10	86.73	85.10	91.13	92.07	89.05	76.14	79.12	75.46	78.56	72.11	122.94	114.01	109.03	104.72	107.40	98.79
	Females	..	..	..	11.85	14.23	12.69	13.69	12.25	12.55	11.53	11.67	13.35	14.31	15.19	22.98	20.63	22.46	19.19	19.48	21.05
......malignant neoplasm of larynx, trachea, bronchus and lung (C32-C34)	Males and females	40.09	39.55	39.66	43.17	40.10	38.92	41.59	40.39	39.72	34.78	35.63	35.79	36.81	35.43	57.31	54.21	54.18	50.39	52.19	49.50
	Males	87.73	86.85	86.53	96.05	84.76	83.10	89.50	89.63	87.29	74.48	77.59	74.60	76.83	69.99	120.97	110.84	107.02	103.00	105.31	96.71
	Females	10.64	11.47	11.20	11.46	13.55	12.37	13.01	11.54	12.08	11.45	11.42	13.09	13.40	14.84	22.07	19.65	21.78	18.57	18.72	19.90
....malignant melanoma of skin (C43)	Males and females	2.93	2.31	2.36	2.44	2.94	2.58	3.59	2.76	3.35	3.74	3.37	3.21	2.51	2.69	4.92	4.59	2.94	3.96	3.68	3.15
	Males	2.51	2.78	3.04	2.38	3.64	3.09	3.65	3.26	4.50	3.63	3.71	4.54	2.95	3.97	6.31	5.33	2.85	4.38	3.97	3.98
	Females	3.28	1.98	2.09	2.58	2.64	2.30	3.59	2.35	2.48	4.00	3.33	2.45	2.64	1.98	4.03	3.89	2.76	2.03	3.16	2.26
....malignant neoplasm of breast (C50)	Males and females	17.71	16.12	15.44	14.44	13.97	14.38	13.73	12.14	13.50	13.18	12.36	13.81	14.19	11.42	20.02	19.21	18.91	20.17	19.69	17.68
	Males	0.41	0.98	0.44	0.45	0.33	0.16	0.27	0.18	0.14	0.00	0.00	0.44	0.30	0.60	0.47	0.64	0.50	0.68	0.00	0.27
	Females	30.17	26.75	25.24	23.89	23.00	23.76	22.53	20.00	22.46	21.82	20.32	22.56	23.24	18.88	31.19	27.14	26.23	29.44	27.68	27.43
....malignant neoplasm of cervix uteri (C53)	Males and females	3.92	3.67	3.85	3.83	3.61	3.88	3.77	3.27	4.31	3.53	4.32	4.38	4.27	3.53	5.00	4.52	4.54	5.21	3.88	4.76
	Males	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	Females	6.73	6.32	6.59	6.66	6.22	6.69	6.49	5.74	7.35	6.07	7.52	7.45	7.53	6.06	8.49	7.26	7.62	7.68	6.44	7.72
....malignant neoplasm of other parts of uterus (C54, C55)	Males and females	4.07	3.60	2.99	2.77	3.67	3.06	3.72	2.96	3.71	2.42	2.69	2.34	2.30	2.89	3.89	4.53	3.85	4.38	3.68	4.14
	Males	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	Females	6.54	5.73	4.59	4.42	5.91	4.83	6.00	4.65	5.89	3.77	4.35	3.60	3.59	4.63	5.88	6.13	5.54	6.56	5.13	6.32
....malignant neoplasm of ovary (C56)	Males and females	6.84	7.25	6.17	6.88	5.98	6.65	5.47	6.04	4.84	5.98	4.60	5.67	4.69	4.14	8.90	7.84	6.84	7.33	6.81	6.33
	Males	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	Females	11.30	11.76	10.21	11.37	10.10	11.09	9.07	9.80	7.83	9.74	7.40	9.54	7.75	6.82	14.29	11.17	9.85	11.92	10.55	9.57
....malignant neoplasm of prostate (C61)	Males and females	9.73	8.06	9.02	9.50	10.84	11.43	10.33	9.48	11.79	11.00	11.82	9.85	11.32	10.75	21.14	22.51	20.19	20.57	21.39	20.70
	Males	32.76	26.87	30.25	29.93	36.40	37.30	33.05	29.58	37.27	36.40	38.15	31.77	35.54	33.81	70.60	65.42	57.22	59.54	59.61	55.80
	Females	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
....malignant neopsasm of kidney (C64)	Males and females	..	..	..	6.65	6.60	6.46	6.36	6.43	6.17	6.17	5.34	6.04	6.84	6.54	9.80	12.27	9.89	10.43	9.62	7.63
	Males	..	..	..	11.62	12.42	12.32	11.38	9.77	10.06	10.78	8.20	10.96	11.87	11.17	17.49	16.53	14.59	15.51	16.30	10.87
	Females	..	..	..	3.52	3.19	3.16	3.29	4.19	3.61	3.43	3.83	3.23	3.88	3.94	5.80	7.01	5.27	6.48	4.15	4.73
....malignant neoplasm of bladder (C67)	Males and females	4.52	3.77	4.46	4.52	5.42	5.12	4.46	4.01	4.47	5.05	4.87	5.31	4.08	5.03	7.73	8.01	8.50	8.28	8.35	8.84
	Males	9.25	8.34	11.32	8.58	12.62	12.89	9.92	9.00	10.39	12.02	10.22	12.97	9.90	11.23	18.53	15.78	17.48	16.03	14.99	15.80
	Females	2.23	1.68	1.34	2.42	1.97	1.69	2.18	1.36	1.81	1.73	2.24	1.85	1.33	2.12	3.17	2.27	3.01	2.78	2.94	2.59
....malignant neoplasms of lymphoid/haemotopoietic tissue (C81-C96)	Males and females	..	..	..	12.74	15.31	12.85	12.88	14.49	12.24	12.39	13.55	13.73	13.78	14.87	22.57	24.21	31.31	23.83	21.61	23.06
	Males	..	..	..	20.54	22.71	17.92	17.00	20.06	15.79	19.25	18.62	17.87	18.32	20.43	30.86	30.95	44.43	32.61	31.70	29.85
	Females	..	..	..	8.22	10.90	9.68	11.13	11.53	10.53	9.34	10.22	11.38	11.54	11.62	18.43	18.37	22.18	17.62	14.18	16.14
......leukemia (C91-C95)	Males and females	5.46	6.16	5.79	6.02	6.99	7.00	6.88	7.81	6.88	6.16	5.93	6.33	6.97	7.00	9.74	9.98	10.74	10.92	8.07	8.59
	Males	7.40	6.77	7.50	9.65	9.59	10.69	9.18	11.72	9.01	10.80	9.11	7.58	10.62	9.89	14.40	12.63	15.65	15.54	13.17	10.25
	Females	4.66	5.75	4.95	3.90	5.33	4.76	6.30	5.85	6.15	4.16	3.96	5.57	5.21	5.48	7.42	7.42	7.55	7.46	5.07	5.85
Endocrine, nutritional and metabolic diseases (E00-E90)	Males and females	9.07	10.56	8.94	10.58	17.48	13.89	14.22	14.97	13.67	12.07	9.23	9.37	8.24	8.22	13.10	12.04	15.98	16.77	18.15	21.47
	Males	10.45	10.33	6.97	8.12	19.98	14.96	13.74	17.92	13.79	14.94	12.00	10.01	9.93	9.72	12.46	12.04	19.52	19.33	19.44	21.73
	Females	8.22	10.59	10.02	11.85	15.19	12.97	13.86	12.62	12.77	9.81	7.38	9.08	6.74	7.02	12.91	10.67	10.83	11.44	14.10	15.55
..diabetes mellitus (E10-E14)	Males and females	7.30	9.36	7.56	8.84	15.46	12.01	12.63	12.84	11.37	10.83	7.71	7.97	6.82	6.92	11.78	10.44	14.21	14.85	17.08	18.01
	Males	8.93	9.30	5.50	7.41	18.25	13.22	12.22	15.78	11.40	13.59	10.63	8.74	8.38	8.64	11.50	11.17	17.27	16.70	18.56	18.23
	Females	6.43	9.15	8.48	9.45	12.97	11.09	12.23	10.57	10.65	8.83	5.85	7.56	5.53	5.60	11.42	8.74	9.44	10.16	12.98	12.95
Diseases of the blood and blood-forming organs (D50-D89)	Males and females	0.76	1.04	0.75	0.95	0.84	0.82	0.87	0.88	0.84	0.53	0.56	0.92	0.61	0.87	1.48	2.06	1.53	2.54	2.08	2.10
	Males	0.77	1.09	1.31	1.10	0.47	0.67	1.56	0.85	1.01	0.40	1.04	0.89	0.91	0.48	2.28	1.70	1.64	2.75	2.22	0.85
	Females	0.56	1.21	0.29	0.82	0.92	1.05	0.43	0.85	0.62	0.65	0.34	0.94	0.44	1.04	1.13	1.66	0.92	2.02	1.29	1.93
..anaemia (D50-D64)	Males and females	0.50	0.28	0.52	0.40	0.30	0.30	0.36	0.39	0.45	0.17	0.23	0.47	0.42	0.57	0.98	1.29	0.98	1.09	0.75	1.11
	Males	0.45	0.14	1.00	0.00	0.17	0.00	0.58	0.54	0.69	0.00	0.35	0.45	0.53	0.31	1.48	1.04	0.77	1.13	0.62	0.00
	Females	0.42	0.29	0.14	0.67	0.35	0.53	0.21	0.31	0.25	0.27	0.16	0.53	0.41	0.71	0.81	1.02	0.57	0.65	0.52	1.10
Mental, behavioural disorders (F00-F99)	Males and females	1.73	4.55	4.15	10.55	9.82	13.00	10.66	17.12	12.30	9.25	7.90	7.68	8.19	6.06	8.46	8.00	8.45	11.37	10.63	12.90
	Males	3.11	6.81	7.30	16.48	16.88	19.89	17.74	29.35	20.25	13.35	13.43	12.50	14.10	10.14	14.05	12.01	11.37	15.01	14.58	12.89
	Females	0.70	2.66	1.63	5.36	3.72	7.25	5.24	7.02	5.97	5.52	3.68	3.66	3.52	2.70	4.29	3.07	3.75	5.28	4.71	6.97
..mental and behavioural disorders due to use of alcohol (F10)	Males and females	1.46	4.34	4.10	10.28	9.58	12.93	9.72	15.27	10.70	7.74	6.12	6.44	6.80	4.34	4.65	4.63	4.35	4.50	3.80	3.43
	Males	2.73	6.52	7.30	16.15	16.74	19.75	16.25	26.68	18.78	12.82	10.82	11.12	12.17	8.00	8.97	9.29	8.07	8.70	7.63	6.44
	Females	0.41	2.51	1.57	5.15	3.51	7.25	4.43	5.60	4.32	3.73	2.20	2.61	2.36	1.31	1.11	0.86	1.28	1.06	0.79	0.81
..drug dependence and toxicomania (F11-F16, F18, F19)	Males and females	..	..	..	..	0.07	0.07	0.00	0.00	0.00	0.07	0.00	0.07	0.00	0.00	0.07	0.15	0.00	0.00	0.00	0.00
	Males	..	..	..	..	0.14	0.14	0.00	0.00	0.00	0.14	0.00	0.14	0.00	0.00	0.14	0.29	0.00	0.00	0.00	0.00
	Females	..	..	..	..	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Diseases of the nervous system and sense organs (G00-H95)	Males and females	11.99	15.32	15.00	13.25	14.64	15.97	17.12	16.19	13.85	14.99	13.35	14.67	14.33	15.53	21.64	25.36	23.53	24.97	27.00	26.11
	Males	15.29	22.44	21.09	20.53	19.41	21.48	24.86	21.40	18.19	22.98	15.26	20.95	19.43	20.46	30.36	28.04	28.77	32.24	34.56	35.94
	Females	9.36	10.08	9.99	7.37	10.85	11.60	11.21	12.23	10.42	9.48	11.88	10.53	11.15	12.44	16.36	18.75	17.85	17.04	19.29	17.38
..meningitis (G00-G03)	Males and females	1.19	1.07	1.16	1.09	0.68	0.96	1.11	0.60	0.83	0.51	0.61	0.67	0.04	0.30	0.46	0.29	0.45	0.21	0.60	0.49
	Males	1.46	1.40	1.37	1.88	0.78	1.47	2.24	0.98	0.92	0.74	0.16	0.66	0.00	0.10	0.47	0.55	0.37	0.31	1.08	0.77
	Females	0.94	0.67	1.02	0.38	0.71	0.43	0.32	0.26	0.76	0.32	0.90	0.69	0.06	0.48	0.30	0.13	0.35	0.09	0.21	0.33
Diseases of the circulatory system (I00-I99)	Males and females	558.66	552.77	550.29	542.90	508.25	492.17	480.31	459.97	448.15	420.86	406.06	367.41	362.08	347.84	658.49	657.53	639.03	618.93	602.49	568.36
	Males	746.83	758.72	736.28	739.14	694.28	681.97	681.54	650.72	628.19	583.15	561.74	505.21	504.11	459.31	847.35	658.48	653.23	625.88	596.36	565.07
	Females	440.39	425.18	427.77	421.04	388.14	373.57	357.41	341.21	335.51	318.56	309.82	278.39	270.06	271.49	544.64	379.46	361.12	350.96	332.92	315.90
..chronic rheumatic heart diseases (I05-I09)	Males and females	3.94	4.08	3.38	3.14	3.85	1.96	2.13	2.35	1.34	2.15	1.69	1.37	1.10	1.49	1.41	1.22	1.44	2.39	0.36	1.44
	Males	3.66	3.57	3.27	3.29	3.21	1.72	1.81	1.79	1.57	1.61	0.95	1.46	0.91	0.94	0.90	0.33	1.40	1.13	0.22	0.65
	Females	3.87	4.23	3.29	3.11	4.19	2.15	2.21	2.57	1.11	2.29	2.09	1.23	1.16	1.76	1.58	1.45	1.33	2.67	0.50	1.50
..hypertensive diseases (I10-I15)	Males and females	18.69	19.79	24.01	26.02	35.14	36.96	37.61	52.78	74.42	86.44	83.08	84.14	90.61	92.46	207.65	224.31	218.60	234.96	213.13	197.64
	Males	21.60	23.61	28.19	29.41	42.52	45.28	47.40	68.10	94.45	105.11	97.53	96.48	104.94	105.52	228.02	192.16	175.55	201.95	169.85	159.68
	Females	16.06	16.49	20.16	22.56	29.19	30.39	30.32	41.64	60.00	72.32	71.35	73.58	78.22	81.21	190.67	146.41	141.76	143.68	133.03	118.98
..ischaemic heart diseases (I20-I25)	Males and females	329.83	324.77	317.32	307.55	278.11	261.04	251.00	234.55	223.04	203.69	198.35	173.34	169.66	147.00	247.54	266.25	250.33	234.50	221.51	173.08
	Males	456.47	477.86	450.18	437.10	407.08	382.96	373.29	346.75	328.19	296.96	292.49	253.46	255.72	211.96	352.08	285.49	282.18	262.44	245.81	194.67

Data extracted on 18 sept 2020 13:49 UTC (GMT) fromStatistika andmebaas

Information

Please check the i to get information

Combine Queries

This dataset preview is momentarily unavailable.

RV572: Standardized death rate by cause of death and sex

Information